Retatrutide is an investigational medicine being studied in modern metabolic research. Scientists are interested in its unique action on three hormone receptors: GIP, GLP-1, and glucagon. Clinical studies are examining its possible role in weight management and other metabolic conditions. Recent Phase 3 research has reported encouraging results, but research is still continuing.